bearish
Tokyo Kikai Seisakusho (6335) Court Approved Poison Pill Stalemate Extended (Means Selling)
372 Views19 Nov 2021 10:55
SUMMARY
- On 17 November, Tokyo Kikai Seisakusho (6335 JP) announced an agreement with ADC to hold off on issuing the rights against an ADC pledge to not call an EGM.
- On 18 November, the Supreme Court handed down its rejection of the Asia Development Capital (9318 JP) appeals.
- The immediate hostility is dialled back, the stalemate is extended. Every buyer from now on is a potential bagholder.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Tokyo Kikai Seisakusho (6335) Court Approved Poison Pill Stalemate Extended (Means Selling)19 Nov 2021
- Tokyo Kikai Seisakusho (6335) - Poison Pill Approval Appealed and Possible Silver Linings01 Nov 2021
- Tokyo Kikai Seisakusho (6335) - Shareholders Approve Poison Pill23 Oct 2021
x